State Street’s Caribou Biosciences CRBU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$451K Sell
358,163
-1,283,018
-78% -$1.62M ﹤0.01% 3635
2025
Q1
$1.5M Sell
1,641,181
-16,380
-1% -$15K ﹤0.01% 3337
2024
Q4
$2.64M Buy
1,657,561
+39,318
+2% +$62.5K ﹤0.01% 3228
2024
Q3
$3.17M Buy
1,618,243
+2,664
+0.2% +$5.22K ﹤0.01% 3158
2024
Q2
$2.65M Sell
1,615,579
-4,731,742
-75% -$7.76M ﹤0.01% 3205
2024
Q1
$32.6M Buy
6,347,321
+1,227,655
+24% +$6.31M ﹤0.01% 1945
2023
Q4
$29.3M Sell
5,119,666
-233,723
-4% -$1.34M ﹤0.01% 1993
2023
Q3
$25.6M Buy
5,353,389
+4,283,243
+400% +$20.5M ﹤0.01% 2021
2023
Q2
$4.55M Sell
1,070,146
-2,285,146
-68% -$9.71M ﹤0.01% 3037
2023
Q1
$17.8M Buy
3,355,292
+156,399
+5% +$830K ﹤0.01% 2313
2022
Q4
$20.1M Buy
3,198,893
+803,423
+34% +$5.05M ﹤0.01% 2244
2022
Q3
$25.3M Buy
2,395,470
+1,597,870
+200% +$16.9M ﹤0.01% 2050
2022
Q2
$4.33M Buy
797,600
+54,578
+7% +$296K ﹤0.01% 3165
2022
Q1
$6.82M Buy
743,022
+330,074
+80% +$3.03M ﹤0.01% 3029
2021
Q4
$6.23M Buy
412,948
+129,359
+46% +$1.95M ﹤0.01% 3135
2021
Q3
$6.77M Buy
+283,589
New +$6.77M ﹤0.01% 3078